Early Human Trials Suggest Cellular Reprogramming May Extend Longevity

Early Human Trials Suggest Cellular Reprogramming May Extend Longevity

Audio narration · Coming soon

The first human trials of cellular reprogramming aimed at extending longevity are underway. Initial indications suggest that this approach may be effective, attracting interest from billionaires invested in longevity research.

Why this matters

PRISM scored this story 65/100 for interest.

Originally published by gnews